Heathcliff Dorado Garcia Selected Research

Neuroblastoma

1/2021	Combined inhibition of Aurora-A and ATR kinase results in regression of MYCN-amplified neuroblastoma.
4/2020	Publisher Correction: Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastoma.
1/2019	Prohibitin promotes de-differentiation and is a potential therapeutic target in neuroblastoma.
11/2017	Therapeutic targeting of PGBD5-induced DNA repair dependency in pediatric solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Heathcliff Dorado Garcia Research Topics

Disease

4	Neuroblastoma 01/2021 - 11/2017
3	Neoplasms (Cancer) 01/2019 - 11/2017
2	Medulloblastoma 01/2019 - 11/2017
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2021
1	Ewing Sarcoma (Sarcoma, Ewing) 11/2017
1	Rhabdoid Tumor (Rhabdoid Tumors) 11/2017

Drug/Important Bio-Agent (IBA)

1	Phosphotransferases (Kinase)IBA 01/2021
1	Circular DNAIBA 04/2020
1	ProhibitinsIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	BI 6727IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	TransposasesIBA 11/2017
1	Cisplatin (Platino)FDA LinkGeneric 11/2017
1	DNA (Deoxyribonucleic Acid)IBA 11/2017
1	ceralasertibIBA 11/2017

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2019